Caplin Point Laboratories arm gets USFDA gesture for Neostigmine Methylsulfate Injection Kumar Jeetendra | April 22, 2021 New Delhi: Caplin Point Laboratories on Thursday said its subsidiary has received approval from the US health regulator for Neostigmine Methylsulfate Injection. Neostigmine Methylsulfate Injection is a cholinesterase inhibitor and is indicated for the reversal of the effects of non-depolariSing neuromuscular blocking agents (NMBAs) after surgery. “Caplin Steriles Ltd (Caplin) has been granted final approval …
Johnson and Johnson says in talks with Indian government for preliminary of single-portion vaccine Kumar Jeetendra | April 9, 2021 Johnson & Johnson is in talks with India’s government to start a clinical trial of its single-dose COVID-19 vaccine in the country, the company said on Friday. The U.S. drugs and health care giant’s vaccine is currently approved for use in the USA, the European Union and other countries including Thailand and South Africa. The …
ENPICOM and Viroclinics-DDL receive joint MIT Zuid subsidy to accelerate and improve antibody and vaccine discovery and development Kumar Jeetendra | April 6, 2021 ‘s-Hertogenbosch (The Netherlands) – March 30, 2021 – Life Science Newswire – Viroclinics-DDL, a state-of-the-art Contract Research Organization specialized in molecular diagnostic testing and assay development, and ENPICOM, an innovative bioinformatics software engineering company, announced the approval of their joint MIT Zuid subsidy (SME Innovation Stimulation Top Sectors South Holland) application. This R&D partnership project …
Zydus Cadila, Alembic Pharma arms review drugs in US Kumar Jeetendra | March 31, 2021 New Delhi, Mar 30 (PTI) US-based arms of national pharma companies Zydus Cadila and Alembic Pharmaceuticals are recalling one drug each in the US after receiving complaints against the products. Administration of crystallized Acyclovir Sodium Injection, 50 mg/mL has a possibility of life threatening adverse consequences, it added. “To date, Zydus Pharmaceuticals (USA) Inc has …
Pfizer, BioNTech dispatch COVID-19 antibody trial in kids under 12 Kumar Jeetendra | March 26, 2021 Pfizer Inc and German partner BioNTech SE began testing their COVID-19 vaccine in children under 12, with hopes of expanding vaccination to that age range from ancient 2022, the US drugmaker said on Thursday. The first volunteers in the early-stage trial were given their first shots on Wednesday, Pfizer spokesperson Sharon Castillo said. The Pfizer/BioNTech …
Glenmark Pharmaceuticals gets USFDA gesture for conventional antipsychotic drug Kumar Jeetendra | March 24, 2021 Drug firm Glenmark Pharmaceuticals on Wednesday said it has received final approval from the US health regulator because of its generic phenothiazine antipsychotic Chlorpromazine Hydrochloride tablets. “The company has received approval from the United States Food and Drug Administration (USFDA) for Chlorpromazine Hydrochloride tablets USP, in the strengths of 10 mg, 25 mg, 50 mg, …
Cipla Therapeutics and SIGA Technologies Announce Strategic Partnership to support innovation and provide access to novel antibacterial drugs against biothreats Kumar Jeetendra | March 23, 2021 March 23, 2021, MUMBAI – Cipla Therapeutics, an affiliate of Cipla Limited (BSE: 500087; NSE: CIPLA EQ; referred to as “Cipla”) and SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market announced entering into a strategic partnership to deliver sustained innovation and access to novel antibacterial drugs, particularly …
Cipla pledges support to ‘Terra Carta’, for a sustainable future Kumar Jeetendra | March 19, 2021 Mumbai; March 19, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced that it has pledged support to ‘Terra Carta’, a landmark charter that has been drawn up to put sustainability at the heart of the private sector. The charter is part of HRH The Prince of Wales’ Sustainable Markets …
Piramal Enterprises to take care of COVID vaccination costs for representatives taking jabs in India Kumar Jeetendra | March 15, 2021 Piramal Enterprises on Monday said it will pay for the cost of COVID-19 vaccination for all its employees and their immediate family members that get the jabs in India. The business will absorb the cost of COVID-19 vaccination for all its employees and their immediate family members who are eligible and choose to get the …
Sun Pharma, Dr Reddy’s, Aurobindo recall products in the U.S. market Kumar Jeetendra | March 14, 2021 Leading home grown drug makers Sun Pharma, Dr Reddy’s Laboratories, Aurobindo Pharma and Jubilant Pharma are remembering products in the U.S. market, the world’s largest market for pharmaceutical products, for various reasons. As per the latest Enforcement Report from the U.S. Food and Drug Administration (USFDA), Sun Pharma is remembering Cequa ophthalmic solution, which is …
Sanofi to begin human preliminaries of its second COVID vaccine candidate Kumar Jeetendra | March 12, 2021 French pharmaceutical company Sanofi on Friday announced the launch of human trials of its next COVID-19 vaccine, with its first still in the testing period after having fallen behind in development. Sanofi and US firm Translate Bio are growing the vaccine based on messenger RNA technology. The phase 1 and 2 trials aim to confirm …
Dr Reddy’s gets 3 perceptions from USFDA for US-based API plant Kumar Jeetendra | March 10, 2021 Dr Reddy’s Laboratories on Wednesday said the US health regulator has issued a Form 483 with three observations after inspecting its Production facility in Middleburg, New York. The audit of the business’s active pharmaceutical ingredients (API) manufacturing plant at Middleburg, New York has been completed from the US Food and Drug Administration (USFDA), the Hyderabad-based …
